The recently launched Dubai Metaverse Strategy by His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and Chairman of Dubai Executive Council, has encouraged QUINT, a DeFi project headquartered in Dubai, to bring philanthropy to the DeFi world.
The founders of QUINT, the project championing the mainstream adoption of DeFi, metaverse, token and blockchain technologies, have donated an equivalent value of USD 16 million to Al Jalila Foundation, a member of the Mohammed Bin Rashid Al Maktoum Global Initiatives, dedicated to transforming lives through medical innovation.
Also Read: EGFR TKI H002 From Redcloud Bio Completes First Dose In Non-small Cell Lung Cancer
The donation, the first of its kind in the UAE and the largest of its kind in the world, was made to support Hamadan Bin Rashid Cancer Charity Hospital through a specially-devised locking and vesting mechanism that will make the required funds available to Al Jalila Foundation over the 3-year construction of the hospital’s bone marrow transplant centre. After the full realisation of the donation, the facility will be named “QUINT Bone Marrow Transplant Centre” upon its launch. The Developing team and Strategic Partners of the QUINT token have also contributed generously towards this donation.
Dr. Abdul Kareem Al Olama, CEO at Al Jalila Foundation, said: “As a philanthropic organisation we rely on charitable donations and we are always seeking innovative ways to expand our donation channels for ease of convenience for donors from all around the world to support our programmes. Crypto philanthropy has emerged as an important and sustainable source of fundraising for charities, giving donors greater opportunities to support humanitarian causes. We are grateful to QUINT for their generous contribution that will have a great impact on the lives of adults and children suffering from cancer.”
Bone marrow transplant (also known as stem cell transplant) is a medical procedure that infuses healthy stem cells to replace damaged or diseased bone marrow. This treatment is usually for cancers such as leukaemia, lymphoma, or other similar life-threatening conditions. The replacement bone marrow or stem cells can come from the patient themselves (autologous transplantation) or from a donor (allogeneic transplantation).